SCHEMBL4280412

SCHEMBL4280412

O=C(O)[C@@](O)(Cl)[C@H](O)[C@H](O)CO

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.37
LMNA P02545 2/20 0.34
USP2 O75604 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
OR51E2 Q9H255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
CPT2 P23786 1/20 0.30
ACLY P53396 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817366 0.87 PDE4A (0.43) PDE4ALMNAUSP2SLCO1B1OR51E2
SCHEMBL29879125 0.87 PDE4A (0.43) PDE4ALMNAUSP2SLCO1B1OR51E2
SCHEMBL11122974 0.80 PDE4A (0.35) PDE4ALMNAL3MBTL1
SCHEMBL11117477 0.77 PDE4A (0.33) PDE4A
SCHEMBL31224147 0.76 PDE4A (0.39) PDE4ALMNAUSP2SLCO1B1OR51E2
SCHEMBL7534971 0.76 PDE4A (0.39) PDE4ALMNAUSP2SLCO1B1OR51E2
SCHEMBL9280372 0.76 PDE4A (0.39) PDE4ALMNAUSP2SLCO1B1OR51E2
SCHEMBL6753289 0.73 PDE4A (0.41) PDE4ALMNAUSP2SLCO1B1OR51E2
SCHEMBL21313126 0.73 CPT2 (0.39) PDE4ALMNAUSP2SLCO1B1OR51E2
SCHEMBL6295932 0.73 TSHR (0.38) PDE4ALMNAUSP2SLCO1B1OR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325208-A1 Biosynthesis of Salinosporamide A and Analogs and Methods Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2009-12-31 US disclosed
WO-2008002600-A2 BIOSYNTHESIS OF SALINOSPORAMIDE A AND ANALOGS AND METHODS THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-01-03 WO disclosed